| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colon
|
Yang, Xiao
|
|
|
57 |
C |
p.
|
artikel
|
| 2 |
Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells
|
Chandrashekar, Darshan S.
|
|
|
57 |
C |
p.
|
artikel
|
| 3 |
Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics
|
Niu, Zeqi
|
|
|
57 |
C |
p.
|
artikel
|
| 4 |
Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract
|
Chen, Hongyun
|
|
|
57 |
C |
p.
|
artikel
|
| 5 |
Corrigendum to “Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment” [Neoplasia, Volume 22, Issue 2 (2020) 111–119]
|
Kregel, Steven
|
|
|
57 |
C |
p.
|
artikel
|
| 6 |
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]
|
Gajula, Rajendra P.
|
|
|
57 |
C |
p.
|
artikel
|
| 7 |
Distinction of papillary and adamantinomatous craniopharyngioma: Clinical features, surgical nuances and hypothalamic outcomes
|
Yang, Le
|
|
|
57 |
C |
p.
|
artikel
|
| 8 |
ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer
|
Cai, Zhonglin
|
|
|
57 |
C |
p.
|
artikel
|
| 9 |
FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cells
|
You, Zhongsheng
|
|
|
57 |
C |
p.
|
artikel
|
| 10 |
Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer
|
Yao, Kuo
|
|
|
57 |
C |
p.
|
artikel
|
| 11 |
Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer
|
Zhang, Jingjing
|
|
|
57 |
C |
p.
|
artikel
|
| 12 |
NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathway
|
Liu, Wenhong
|
|
|
57 |
C |
p.
|
artikel
|
| 13 |
Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells
|
Araki, Keigo
|
|
|
57 |
C |
p.
|
artikel
|
| 14 |
Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer
|
Peters, Pamela N.
|
|
|
57 |
C |
p.
|
artikel
|
| 15 |
PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation
|
Huang, Dennis
|
|
|
57 |
C |
p.
|
artikel
|
| 16 |
PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway
|
Hu, Jing
|
|
|
57 |
C |
p.
|
artikel
|
| 17 |
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation
|
Huang, Yingwei
|
|
|
57 |
C |
p.
|
artikel
|
| 18 |
Probing the glioma micro-environment: Analysis using biopsy in combination with ultra-fast cyclic immunolabeling
|
van Solinge, Thomas S.
|
|
|
57 |
C |
p.
|
artikel
|
| 19 |
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin
|
Kuzmanov, Aleksandar
|
|
|
57 |
C |
p.
|
artikel
|
| 20 |
Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape
|
Simard, Manon A
|
|
|
57 |
C |
p.
|
artikel
|
| 21 |
Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy
|
Schneider, Hanna Elisabeth
|
|
|
57 |
C |
p.
|
artikel
|
| 22 |
The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletions
|
Fu, Jen-Fen
|
|
|
57 |
C |
p.
|
artikel
|
| 23 |
Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study
|
Li, Ying
|
|
|
57 |
C |
p.
|
artikel
|
| 24 |
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression
|
Li, Xiang
|
|
|
57 |
C |
p.
|
artikel
|
Tijdschrift beschrijving